首页> 美国卫生研究院文献>International Journal of Molecular Sciences >Pharmacokinetic Comparison of Ferulic Acid in Normal and Blood Deficiency Rats after Oral Administration of Angelica sinensis Ligusticum chuanxiong and Their Combination
【2h】

Pharmacokinetic Comparison of Ferulic Acid in Normal and Blood Deficiency Rats after Oral Administration of Angelica sinensis Ligusticum chuanxiong and Their Combination

机译:口服当归川and及其组合后阿魏酸在正常和血虚大鼠中的药代动力学比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Radix Angelica Sinensis (RAS) and Rhizome Ligusticum (RLC) combination is a popular herb pair commonly used in clinics for treatment of blood deficiency syndrome in China. The aim of this study is to compare the pharmacokinetic properties of ferulic acid (FA), a main bioactive constituent in both RAS and RLC, between normal and blood deficiency syndrome animals, and to investigate the influence of compatibility of RAS and RLC on the pharmacokinetic of FA. The blood deficiency rats were induced by injecting 2% Acetyl phenylhydrazine (APH) on the first day, every other day, to a total of five times, at the dosage of 100, 50, 50, 30, 30 mg/kg body mass, respectively. Quantification of FA in rat plasma was achieved by using a simple and rapid HPLC method. Plasma samples were collected at different time points to construct pharmacokinetic profiles by plotting drug concentration versus time, and estimate pharmacokinetic parameters. Between normal and blood deficiency model groups, both AUC(0–t) and Cmax of FA in blood deficiency rats after RAS-RLC extract administration increased significantly (P < 0.05), while clearance (CL) decreased significantly. Among three blood deficiency model groups, t1/2α, Vd, AUC(0–t) and AUC(0–∞) all increased significantly in the RAS-RLC extract group compared with the RAS group. The results indicated that FA was absorbed better and eliminated slower in blood deficiency rats; RLC could significantly prolong the half-life of distribution, increase the volume of distribution and the absorption amount of FA of RAS in blood deficiency rats, which may be due to the synergic action when RAS and RLC were used together to treat blood deficiency syndrome.
机译:当归(RAS)和女贞(RLC)的组合是一种流行的草药对,在中国临床上普遍用于治疗血液缺乏综合症。这项研究的目的是比较正常和血液缺乏症候群动物之间的RAS和RLC中主要生物活性成分阿魏酸(FA)的药代动力学特性,并研究RAS和RLC的相容性对药代动力学的影响。 FA。在隔天的第一天,每隔一天注射2%乙酰基苯肼(APH),共五次,以100、50、50、30、30 mg / kg体重的剂量诱导血虚大鼠,分别。大鼠血浆中FA的定量是通过简单快速的HPLC方法实现的。在不同时间点收集血浆样品,通过绘制药物浓度与时间的关系来构建药代动力学曲线,并估算药代动力学参数。在正常和血液缺乏模型组之间,施用RAS-RLC提取物后,血液缺乏大鼠中FA的AUC(0–t)和Cmax均显着增加(P <0.05),而清除率(CL)则显着降低。在三个血虚模型组中,与RAS组相比,RAS-RLC提取物组中的t1 /2α,Vd,AUC(0-t)和AUC(0-∞)均显着增加。结果表明,血虚大鼠体内FA吸收较好,消除速度较慢。 RLC可以显着延长血虚大鼠RAS的半衰期,增加RAS的FA的分布量和吸收量,这可能是由于RAS和RLC共同治疗血虚证的协同作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号